Joseph Michael Fitzgerald Boston Scientific Corp (BSX) insider trading activity

Joseph Michael Fitzgerald is EVP & Group Pres, Cardiology of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 178,342 shares of BSX, which is worth approximately $18.3 Million. The most recent transaction as insider was on Oct 07, 2024, when has been sold 132,527 shares (Common Stock) at a price of $85.0 per share, resulting in proceeds of $11,264,795. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 178K

0% 3M change

6.38% 12M change

Total Value Held $18.3 Million

Joseph Michael Fitzgerald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 07 2024	SELL Open market or private sale	$11,264,795 $85.0 p/Share	132,527 Reduced 45.23%	160,467 Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$2,463,415 $21.12 p/Share	116,639 Added 28.47%	292,994 Common Stock
Aug 28 2024	SELL Open market or private sale	$1,130,560 $80.0 p/Share	14,132 Reduced 7.42%	176,355 Common Stock
May 13 2024	SELL Bona fide gift	-	2,380 Reduced 1.23%	190,487 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$120,384 $65.82 p/Share	1,829 Reduced 0.94%	192,867 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	3,706 Added 1.87%	194,696 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$135,391 $65.82 p/Share	2,057 Reduced 1.07%	190,990 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	4,167 Added 2.11%	193,047 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$118,870 $65.82 p/Share	1,806 Reduced 0.95%	188,880 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	3,960 Added 2.03%	190,686 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$131,240 $65.95 p/Share	1,990 Reduced 1.05%	186,726 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	4,362 Added 2.26%	188,716 Common Stock
Feb 12 2024	SELL Bona fide gift	-	6,000 Reduced 3.15%	184,354 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	-	16,450 Reduced 7.95%	190,354 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	33,332 Added 13.88%	206,804 Common Stock
Jan 12 2024	SELL Open market or private sale	$699,600 $60.0 p/Share	11,660 Reduced 6.3%	173,472 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$630,591 $57.81 p/Share	10,908 Reduced 5.56%	185,132 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	21,799 Added 10.01%	196,040 Common Stock
Dec 29 2023	SELL Open market or private sale	$4,711,550 $57.5 p/Share	81,940 Reduced 31.99%	174,241 Common Stock
Dec 29 2023	BUY Exercise of conversion of derivative security	$949,062 $16.31 p/Share	58,189 Added 18.51%	256,181 Common Stock
Sep 20 2023	SELL Open market or private sale	$872,685 $55.0 p/Share	15,867 Reduced 7.42%	197,992 Common Stock
May 16 2023	SELL Open market or private sale	$3,394,970 $53.6 p/Share	63,339 Reduced 22.85%	213,859 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	$744,526 $13.08 p/Share	56,921 Added 17.04%	277,198 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$88,900 $46.23 p/Share	1,923 Reduced 0.87%	220,277 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	3,895 Added 1.72%	222,200 Common Stock

JMF

Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account